Filing Details

Accession Number:
0001209191-11-017975
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-15 13:28:25
Reporting Period:
2011-03-11
Filing Date:
2011-03-15
Accepted Time:
2011-03-15 13:28:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1514588 Adam Havey 2273 Research Blvd., Suite 400
Rockville MD 20850
Evp, Biodefense Division No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-11 6,667 $7.00 11,331 No 4 M Direct
Common Stock Disposition 2011-03-11 6,667 $19.20 4,664 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2011-03-11 6,667 $0.00 6,667 $7.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-03-10 No 4 M Direct
Footnotes
  1. This option is fully vested.